Objective Comparing the diagnostic values for the malignant obstruction diseases of biliary tract between endoscopic retrograde cholangiopancreatography(ERCP)and MR cholangiopancreatography (MRCP). Methods Parallel analysis for the ERCP and MRCP data of 142 malignancies confirmed by surgery and/or ERCP among 383 biliary tract patients was retrospectively carried out. Results MRCP and ERCP were performed with exploration of 137 cases,showing the total conformity of 96.4%; together with localization conformities of 92.3% and 87.3%,qualitative conformities of 78.5% and 89.8% respectively. Conclusions In diagnosing the malignant obstructing disease of biliary tract,MRCP has the advantages in convenience,safety and low false negative,but with higher false positive than ERCP; however,if combined with ERCP can get higher positive conformity.(J Intervent Radiol,2007,16: 673-675)

Overexpression of exogenous lineage-determining factors succeeds in directly reprogramming fibroblasts to various cell types. Several studies have reported reprogramming of fibroblasts into induced cardiac progenitor cells (iCPCs). CRISPR/Cas9-mediated gene activation is a potential approach for cellular reprogramming due to its high precision and multiplexing capacity. Here we show lineage reprogramming to iCPCs through a dead Cas9 (dCas9)-based transcription activation system. Targeted and robust activation of endogenous cardiac factors, including GATA4, HAND2, MEF2C and TBX5 (G, H, M and T; GHMT), can reprogram human fibroblasts toward iCPCs. The iCPCs show potentials to differentiate into cardiomyocytes, smooth muscle cells and endothelial cells . Addition of MEIS1 to GHMT induces cell cycle arrest in G2/M and facilitates cardiac reprogramming. Lineage reprogramming of human fibroblasts into iCPCs provides a promising cellular resource for disease modeling, drug discovery and individualized cardiac cell therapy.